Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 13/20 | 0.37 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.32 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2298232 | 0.97 | FDPS (0.36) | FDPSGGPS1LMNAGRM2GRM3 | |
| Hydrochloric Acid SCHEMBL4158783 | 0.97 | FDPS (0.36) | FDPSGGPS1LMNAGRM2GRM3 | |
| SCHEMBL7528777 | 0.89 | FDPS (0.31) | FDPS | |
| Ether SCHEMBL9377681 | 0.89 | FDPS (0.31) | FDPSALDH1A1 | |
| SCHEMBL28156893 | 0.88 | FDPS (0.33) | FDPSGGPS1 | |
| Acrylic Acid SCHEMBL28624579 | 0.87 | LMNA (0.40) | FDPSLMNAALDH1A1 | |
| SCHEMBL6505412 | 0.86 | FDPS (0.46) | FDPSGGPS1 | |
| SCHEMBL870763 | 0.86 | TSHR (0.39) | FDPSLMNAMEN1ALDH1A1CYP1A2 | |
| Pyrrole SCHEMBL11065072 | 0.85 | FDPS (0.33) | FDPSGGPS1LMNAGRM2GRM3 | |
| SCHEMBL7528768 | 0.84 | CYP2D6 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1087 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4690337-A2 | PHOSPHOROUS ELECTROLYTE ADDITIVES FOR AQUEOUS BATTERIES | Octet Scientific, Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| US-20260031409-A1 | PHOSPHOROUS ELECTROLYTE ADDITIVES FOR AQUEOUS BATTERIES | OCTET SCIENT INC (US) | 2026-01-29 | — | — | US | claimed |
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| US-20250075020-A1 | WATER-RETAINING MATERIAL, WATER-RETAINING PROTON EXCHANGE MEMBRANE, PREPARATION METHOD AND APPLICATION THEREOF | SOUTHERN UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2025-03-06 | — | — | US | claimed |
| WO-2025043316-A1 | PROCESS FOR OBTAINING ANTI-INFLAMMATORY COMPOUNDS, SAID COMPOUNDS, PHARMACEUTICAL COMPOSITION AND USE OF SAID COMPOUNDS AND OF THE PHARMACEUTICAL COMPOSITION | UNIVERSIDADE ESTADUAL DE CAMPINAS (BR) | 2025-03-06 | — | — | WO | claimed |
| US-20240400793-A1 | COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF | MOMENTIVE PERFORMANCE MATERIALS INC. | 2024-12-05 | — | — | US | claimed |
| WO-2024211760-A2 | PHOSPHOROUS ELECTROLYTE ADDITIVES FOR AQUEOUS BATTERIES | Octet Scientific, Inc. (US) | 2024-10-10 | — | — | WO | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| CN-118434796-A | Composition for polyurethane foam, foam prepared therefrom and method thereof | 迈图高新材料公司 | 2024-08-02 | — | — | CN | claimed |
| EP-4396271-A1 | COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF | Momentive Performance Materials Inc. (US) | 2024-07-10 | — | — | EP | claimed |
| JP-2003517458-A | — | — | 2003-05-27 | — | — | JP | claimed |
| EP-1303311-A2 | AMYLOID TARGETING IMAGING AGENTS AND USES THEREOF | Neurochem, Inc. (CA) | 2003-04-23 | — | — | EP | claimed |
| EP-1276483-A2 | COMPOSITIONS AND METHODS FOR TREATING AMYLOIDOSIS USING SULPHONATE DERIVATIVES | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2003-01-22 | — | — | EP | claimed |
| US-20020115717-A1 | Amyloid targeting imaging agents and uses thereof | NEUROCHEM (INTERNATIONAL) LIMITED (GI) | 2002-08-22 | — | — | US | claimed |
| WO-2002007781-A2 | AMYLOID TARGETING IMAGING AGENTS AND USES THEREOF | NEUROCHEM INC. (CA) | 2002-01-31 | — | — | WO | claimed |
| WO-2000064420-A2 | COMPOSITIONS AND METHODS FOR TREATING AMYLOIDOSIS USING SULPHONATE DERIVATIVES | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2000-11-02 | — | — | WO | claimed |
| JP-2000500758-A | — | — | 2000-01-25 | — | — | JP | claimed |
| EP-0862575-A1 | NOVEL GERANYLGERANYL-DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND RELATED PHARMACEUTICAL COMPOSITIONS | LABORATORI BALDACCI Spa (IT) | 1998-09-09 | — | — | EP | claimed |
| EP-0259227-B1 | BENZHYDRYLOXYETHYL PIPERIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Société anonyme: LES LABORATOIRES MERAM (FR) | 1991-12-27 | — | — | EP | claimed |
| EP-0259227-A1 | Benzhydryloxyethyl piperidine derivatives, process for their preparation and pharmaceutical compositions containing them | Société anonyme: LES LABORATOIRES MERAM (FR) | 1988-03-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260031409-A1 | PHOSPHOROUS ELECTROLYTE ADDITIVES FOR AQUEOUS BATTERIES | H1-10, SLC9A1, HAO2 | FDPS 4824/4885GGPS1 4110/4885LMNA 2212/4885 |
| US-20020115717-A1 | Amyloid targeting imaging agents and uses thereof | APP, APBA1, BACE1 | FDPS 1811/4885GGPS1 1132/4885LMNA 1379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.